The Advantage of Nearshore Clinical Biometrics: Our Growth in Costa Rica

At Intego Clinical, our growth strategy is centered on one simple principle: delivering exceptional biometrics services through highly skilled teams that operate as a seamless extension of our clients’ organizations.

As demand for statistical programming, biostatistics, clinical data management, and regulatory-ready data solutions continues to grow across the pharmaceutical and biotechnology industries, we have expanded our investment in Costa Rica as a key location for supporting global clinical development programs.

This expansion reflects more than geographic growth. It represents a long-term commitment to building world-class biometrics center capable of serving sponsors with the quality, responsiveness, and technical expertise required in today’s increasingly complex clinical trial environment.

A Strategic Location for Global Clinical Development

For sponsors operating across North America and Latin America, proximity and collaboration matter.

Costa Rica provides a unique advantage by enabling real-time communication with teams working in U.S. business hours. Unlike offshore models that often require overnight coordination and delayed feedback cycles, our Costa Rican teams collaborate directly with sponsors, CRO partners, and study stakeholders during the same working day.

This alignment translates into faster decision-making, more efficient issue resolution, and stronger project continuity throughout the clinical trial lifecycle.

For many organizations, the ability to work with highly qualified biometrics professionals in a compatible time zone has become an increasingly important factor when selecting strategic partners. Nearshore delivery models help reduce communication barriers, improve responsiveness, and create a more integrated working relationship between sponsors and service providers.

Access to Exceptional Analytical Talent

Costa Rica has earned an international reputation for developing highly skilled professionals in mathematics, statistics, actuarial sciences, computer science, and life sciences.

The country’s strong educational ecosystem has created a deep talent pool with the analytical thinking, problem-solving capabilities, and technical aptitude required for modern clinical research.

At Intego Clinical, we have seen firsthand the quality of Costa Rican professionals entering the biometrics field. Their ability to master complex programming methodologies, regulatory requirements, and advanced statistical concepts has enabled us to build high-performing teams that consistently support studies across multiple therapeutic areas and development phases.

Beyond technical skills, Costa Rican professionals bring strong English proficiency, a collaborative work culture, and a commitment to quality that aligns naturally with the expectations of global pharmaceutical and biotechnology sponsors.

Investing in the Next Generation of Clinical Biometrics Professionals

One of the key components of our growth strategy is talent development.

Many of the most successful statistical programmers begin their careers without prior experience in the pharmaceutical industry. What matters most is analytical capability, intellectual curiosity, and a willingness to learn.

To support this approach, Intego Clinical has developed structured training programs that prepare emerging professionals for careers in clinical research. Through comprehensive education in industry standards, statistical programming, regulatory requirements, and clinical trial processes, we help transform strong academic talent into future biometrics experts.

We have also established collaborations with leading academic institutions, including the University of Costa Rica, to introduce students to the rapidly growing field of clinical biometrics and provide exposure to industry-standard technologies such as SAS and R.

By creating opportunities for students and recent graduates, we are helping build a sustainable pipeline of talent that will support both our clients and the broader life sciences industry for years to come.

Delivering Quality Through Long-Term Team Stability

One of the most important advantages of our Costa Rican operation is the ability to build stable, dedicated teams that develop deep knowledge of sponsor processes, standards, and expectations.

Clinical development programs require continuity. Sponsors benefit when the same experienced professionals remain engaged throughout the life of a study rather than relying on constantly changing resources.

Our investment in Costa Rica allows us to continue building teams that prioritize long-term relationships, knowledge retention, and consistent delivery. This approach helps reduce onboarding time, improve operational efficiency, and create stronger partnerships with our clients.

As our presence grows, so does our ability to provide scalable support across a broad range of biometrics functions while maintaining the high standards of quality and accountability our clients expect.

Supporting the Future of Clinical Research

The future of clinical development will require greater efficiency, stronger data quality, and closer collaboration between sponsors and biometrics partners.

Costa Rica has emerged as an ideal location to support these objectives by combining highly educated talent, geographic accessibility, cultural compatibility, and operational excellence.

For Intego Clinical, investing in Costa Rica is not simply about expansion. It is about creating a delivery model that combines technical excellence with the advantages of nearshore collaboration. By bringing together top analytical talent and real-time client engagement, we are helping sponsors accelerate development timelines, maintain the highest quality standards, and navigate increasingly complex regulatory environments with confidence.

As we continue to grow our presence in Costa Rica, we remain committed to building long-term partnerships with our clients, investing in local talent, and strengthening our role as a trusted biometrics partner for the global pharmaceutical and biotechnology industries. The success of our Costa Rican operations reflects the strength of the country’s workforce and reinforces our belief that the future of clinical biometrics will be driven by teams that combine scientific expertise, operational excellence, and seamless collaboration across borders.